Navigation Links
IOF calls on European citizens to stand tall and speak out for their bones
Date:10/14/2008

As Chair of the EU Osteoporosis Consultation Panel, Prof Juliet Compston urged "scientists, physicians, policymakers, advocates and patients and their families to use the information in this report to identify issues that need attention now. The active support of all EU citizens and their governments is essential if the important goals which remain outstanding are to be realized"

Members of the EU Osteoporosis Consultation Panel, comprised of scientific and health policy experts from all 27 member states who contributed to the report, MEPs who form the European Parliament Osteoporosis Interest Group, and members of the media heard about other global World Osteoporosis Day campaigns that seek to mobilize stakeholders to Stand Tall, and Speak Out.

Speakers from across Europe joined together for the 3rd IOF Women Leaders Roundtable, sharing their stories and encouragement to citizens of all ages to take control of their life by making healthy lifestyle decisions now that pay huge dividends down the road. Working in partnership with national osteoporosis societies, which exist in every EU member state, can create a coordinated voice for action, influencing governments to listen.

EU Commissioner for Health, Androulla Vassiliou, one of the Roundtable speakers, said that "Healthcare in the EU is complex and challenging. Among the Commission's key priorities in improving healthcare are to foster good health in an ageing Europe; to reduce health inequalities inside the Union; and to support dynamic health systems by encouraging cross-border cooperation and the creation of centres of excellence. Today's meeting is a very positive step in identifying how we achieve these goals".

Other Roundtable participants included:

  • Susan Hampshire, film and theatre actress from the UK
  • Barbara Miklič Trk, wife of the President of the Republic of Slovenia
  • Anna Molinari, fashion designer from Italy (regrettably unable to attend
    '/>"/>

Contact: Margaret Walker
mwalker@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New NOAA coral bleaching prediction system calls for low level of bleaching in Caribbean this year
2. Female concave-eared frogs draw mates with ultrasonic calls
3. Root or shoot? EAR calls the shots
4. Core blimey! University of Leicester scientist calls for geological time machine
5. Analysis calls for medical device information to better serve patients and doctors
6. Island monkeys do not recognize big cat calls
7. UC Davis bird-flu expert calls for changes in early-warning system
8. Rice University expert calls for coordination in nanotechnology research
9. American Chemical Society calls green chemistry bill a smart step
10. bioMETRX, Inc. Calls Series B Warrants
11. Major European program for the environment under the spotlight in Lille, France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... Oct. 15, 2014   Neurotechnology , a ... the availability of the VeriLook Surveillance 3.0 ... provides real-time biometric face identification using live video ... cameras. The new version not only identifies faces ... from objects while they are moving through the ...
(Date:10/14/2014)... house fly genome for the first time, revealing robust ... that thrives in pathogen-rich dung piles and garbage heaps. ... Genome Biology , will increase understanding of house ... adapt to resist insecticides, which could lead to novel ... and transmit more than 100 human and animal diseases, ...
(Date:10/14/2014)... LA JOLLA, CA – October 14, 2014 – Scientists ... $6.6 million from the National Institutes of Health (NIH) ... most prevalent virus-induced hemorrhagic fever disease in Africa. The ... disease and why some patients die, while others survive ... researchers to understand the basic mechanism of how Lassa ...
Breaking Biology News(10 mins):VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3House fly genome reveals expanded immune system 2Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2
... anachronism? Or is it a vital part of a ... 2.4 billion more people by the year 2050, the drive ... , But there,s an important downside to this trend, argues ... Montreal, in a paper to be presented Saturday, Feb. 15, ...
... Calif.) When mothers feed their newborns formula in the ... in the second month of life and more likely to ... longer, UC Davis researchers have found. "We are ... hospital can cause problems by reducing how much women breastfeed ...
... Rochelle, NY, February 13, 2014Food spoiling and poisoning caused ... economic problems. The broad scope of antimicrobial approaches to ... and beverages, including a variety of natural and artificial ... in Industrial Biotechnology , a peer-reviewed journal from ...
Cached Biology News:Making biodiverse agriculture part of a food-secure future 2Making biodiverse agriculture part of a food-secure future 3In-hospital formula use deters breastfeeding 2In-hospital formula use deters breastfeeding 3
(Date:10/22/2014)... and BOSTON , Oct. ... ), a leading global specialty pharmaceutical company, and Rhythm, ... granted an exclusive option to acquire Rhythm,s wholly owned ... a peptide ghrelin agonist, for the treatment of diabetic ... Rhythm has completed a successful Phase 2 trial of ...
(Date:10/22/2014)... Involution Studios , a healthcare software ... infographic, Understanding Ebola . The goal of ... to follow informative tool for anyone wanting to know ... prevention. , "As the news has spread in all ... represents not only a healthcare crisis with global impact, ...
(Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
Breaking Biology Technology:Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2
... Longer-term Phase 2 Switching Study, CRANBURY, ... company developing small-molecule, orally administered,pharmacological chaperones for ... that the Company will present positive results ... (isofagomine tartrate) for Gaucher disease,at the American ...
... on the strangeness of the nanoworld, researchers at the ... University of Maryland-College Park have discovered that materials such ... behave as ductile as gold at the nanoscale. Their ... NIST scientists Pradeep Namboodiri and Doo-In Kim and colleagues ...
... Calif., March 12 ,Exelixis, Inc. (Nasdaq: EXEL ) ... executive officer of Exelixis, will present at the,Cowen and ... / 1:00 p.m.,PT on Monday, March 17, 2008. Dr. ... corporate strategy., The presentation will be webcast and ...
Cached Biology Technology:Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 2Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 3Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease 4Nanomaterials show unexpected strength under stress 2
... Ambion's ActivePro In ... from an E.coli lysate, ... protein as well as ... activity than competing kits. ...
... Mouse Serum • Mouse serum is collected off ... and 8-12 weeks of age. Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium Oxalate ... N-05: ACD N-07: CPD ...
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
One-step, microplate or cuvet, colorimetric, linear detection range 0.6 mM to 100 mM. Procedure: 2 min....
Biology Products: